4D Molecular Therapeutics (FDMT)
NASDAQ:FDMT
Want to see FDMT full AI Analyst Report?
4D Molecular Therapeutics (FDMT) Ownership Overview
2.20% Insiders
13.24% Mutual Funds
40.34% Other Institutional Investors
17.86% ETFs
26.36% Public Companies and
Individual Investors
The ownership structure of 4D Molecular Therapeutics (FDMT) stock is a mix of institutional, retail, and individual investors. Approximately 71.44% of the company’s stock is owned by Institutional Investors, 2.20% is owned by Insiders, and 26.36% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Dec 19, 2025 | xxxxxxxxxxxxx | $17822 | |
Oct 27, 2025 | xxxxxxxxxxxxx | $32136 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $47013442 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $201115 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,049,779 | Institution | 9.66% | 48,780,865 | |
| 2,597,856 | Institution | 4.97% | 25,095,289 | |
| 2,147,868 | Institution | 4.11% | 20,748,405 | |
| 2,049,149 | Institution | 3.92% | 19,794,779 | |
| 1,967,782 | Institution | 3.76% | 19,008,774 | |
| 1,602,805 | Institution | 3.07% | 15,483,096 | |
| 1,057,231 | Insider | 2.02% | 10,212,851 | |
| 1,022,073 | Institution | 1.96% | 9,873,225 | |
| 843,751 | Institution | 1.61% | 8,150,635 | |
| 499,365 | Institution | 0.96% | 4,823,866 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,147,868 | Institution | 4.11% | 20,748,405 | |
| 1,022,073 | Institution | 1.96% | 9,873,225 | |
| 843,751 | Institution | 1.61% | 8,150,635 | |
| 499,365 | Institution | 0.96% | 4,823,866 | |
| 437,540 | Institution | 0.84% | 4,226,636 | |
| 356,881 | Institution | 0.68% | 3,447,470 | |
| 267,501 | Institution | 0.51% | 2,584,060 | |
| 232,021 | Institution | 0.44% | 2,241,323 | |
| 165,054 | Institution | 0.32% | 1,594,422 | |
| 158,100 | Institution | 0.30% | 1,527,246 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,654,401 | Institution | 3.16% | 16,395,114 | |
| 1,513,670 | Institution | 2.90% | 14,258,771 | |
| 1,041,925 | Institution | 1.99% | 10,064,996 | |
| 445,816 | Institution | 0.85% | 4,418,037 | |
| 379,382 | Institution | 0.73% | 3,664,830 | |
| 370,854 | Institution | 0.71% | 3,493,445 | |
| 336,675 | Institution | 0.64% | 3,252,281 | |
| 310,600 | Institution | 0.59% | 3,000,396 | |
| 310,600 | Institution | 0.59% | 3,000,396 | |
| 310,600 | Institution | 0.59% | 3,000,396 |
FAQ
Who Owns 4D Molecular Therapeutics (FDMT)?
According to the latest TipRanks data, approximately 40.34% of the company's stock is held by institutional investors, 2.20% is held by insiders, and 26.36% is held by retail investors.
What percentage of 4D Molecular Therapeutics (FDMT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 40.34% of 4D Molecular Therapeutics (FDMT) stock is held by institutional investors.
What percentage of 4D Molecular Therapeutics (FDMT) stock is held by retail investors?
According to the latest TipRanks data, approximately 26.36% of 4D Molecular Therapeutics (FDMT) stock is held by retail investors.
Who owns the most shares of 4D Molecular Therapeutics (FDMT)?
Peter Kolchinsky owns the most shares of 4D Molecular Therapeutics (FDMT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.